Next-generation of selective histone deacetylase inhibitors

Histone deacetylases (HDACs) are clinically validated epigenetic drug targets for cancer treatment. HDACs inhibitors (HDACis) have been successfully applied against a series of cancers. First-generation inhibitors are mainly pan-HDACis that target multiple isoforms which might lead to serious side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feifei, Zhao, Na, Ge, Di, Chen, Yihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065321/
https://www.ncbi.nlm.nih.gov/pubmed/35519364
http://dx.doi.org/10.1039/c9ra02985k

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065321/
https://www.ncbi.nlm.nih.gov/pubmed/35519364
http://dx.doi.org/10.1039/c9ra02985k

Ejemplares similares